Progress Toward the Clinical Application of Patient-specific Pluripotent Stem Cells

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2010 Jan 7

PMID 20051636

Citations 152

Authors

Evangelos Kiskinis

Kevin Eggan

Affiliations

Soon will be listed here.

Abstract

Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells through the exogenous expression of transcription factors. These cells, just like embryonic stem cells, are likely to have a major impact on regenerative medicine, because they self-renew and retain the potential to be differentiated into all cell types of the human body. In this Review, we describe the current state of iPS cell technology, including approaches by which they are generated and what is known about their biology, and discuss the potential applications of these cells for disease modeling, drug discovery, and, eventually, cell replacement therapy.

Citing Articles

Forty Years of the Use of Cells for Cartilage Regeneration: The Research Side.

Roseti L, Cavallo C, Desando G, DAlessandro M, Grigolo B Pharmaceutics. 2025; 16(12.

PMID: 39771600 PMC: 11677864. DOI: 10.3390/pharmaceutics16121622.

Downregulation of the silent potassium channel Kv8.1 increases motor neuron vulnerability in amyotrophic lateral sclerosis.

Huang X, Lee S, Chen K, Kawaguchi R, Wiskow O, Ghosh S Brain Commun. 2024; 6(3):fcae202.

PMID: 38911266 PMC: 11191651. DOI: 10.1093/braincomms/fcae202.

Stem cell-based therapy for fibrotic diseases: mechanisms and pathways.

Taherian M, Bayati P, Mojtabavi N Stem Cell Res Ther. 2024; 15(1):170.

PMID: 38886859 PMC: 11184790. DOI: 10.1186/s13287-024-03782-5.

Stem Cells Reprogramming in Diabetes Mellitus and Diabetic Complications: Recent Advances.

Madkor H, Abd El-Aziz M, El-Maksoud M, Ibrahim I, Ali F Curr Diabetes Rev. 2024; 21(4):21-37.

PMID: 38173073 DOI: 10.2174/0115733998275428231210055650.

Strategies targeting endoplasmic reticulum stress to improve Parkinson's disease.

Wang D, Qu S, Zhang Z, Tan L, Chen X, Zhong H Front Pharmacol. 2023; 14:1288894.

PMID: 38026955 PMC: 10667558. DOI: 10.3389/fphar.2023.1288894.

References

Ebert A, Yu J, Rose Jr F, Mattis V, Lorson C, Thomson J . Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2008; 457(7227):277-80. PMC: 2659408. DOI: 10.1038/nature07677. View

Stadtfeld M, Brennand K, Hochedlinger K . Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol. 2008; 18(12):890-4. PMC: 2819222. DOI: 10.1016/j.cub.2008.05.010. View

Kim D, Kim C, Moon J, Chung Y, Chang M, Han B . Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009; 4(6):472-6. PMC: 2705327. DOI: 10.1016/j.stem.2009.05.005. View

Utikal J, Maherali N, Kulalert W, Hochedlinger K . Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci. 2009; 122(Pt 19):3502-10. PMC: 2746132. DOI: 10.1242/jcs.054783. View

Sommer C, Stadtfeld M, Murphy G, Hochedlinger K, Kotton D, Mostoslavsky G . Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells. 2008; 27(3):543-9. PMC: 4848035. DOI: 10.1634/stemcells.2008-1075. View

Chin M, Mason M, Xie W, Volinia S, Singer M, Peterson C . Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009; 5(1):111-23. PMC: 3448781. DOI: 10.1016/j.stem.2009.06.008. View

Woltjen K, Michael I, Mohseni P, Desai R, Mileikovsky M, Hamalainen R . piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009; 458(7239):766-70. PMC: 3758996. DOI: 10.1038/nature07863. View

Rubin L . Stem cells and drug discovery: the beginning of a new era?. Cell. 2008; 132(4):549-52. DOI: 10.1016/j.cell.2008.02.010. View

Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

10.

Wernig M, Meissner A, Cassady J, Jaenisch R . c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell. 2008; 2(1):10-2. DOI: 10.1016/j.stem.2007.12.001. View

11.

Cowan C, Atienza J, Melton D, Eggan K . Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005; 309(5739):1369-73. DOI: 10.1126/science.1116447. View

12.

Hacein-Bey-Abina S, Garrigue A, Wang G, Soulier J, Lim A, Morillon E . Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest. 2008; 118(9):3132-42. PMC: 2496963. DOI: 10.1172/JCI35700. View

13.

Lamba D, Gust J, Reh T . Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell. 2009; 4(1):73-9. PMC: 2713676. DOI: 10.1016/j.stem.2008.10.015. View

14.

Keirstead H, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K . Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci. 2005; 25(19):4694-705. PMC: 6724772. DOI: 10.1523/JNEUROSCI.0311-05.2005. View

15.

Sridharan R, Tchieu J, Mason M, Yachechko R, Kuoy E, Horvath S . Role of the murine reprogramming factors in the induction of pluripotency. Cell. 2009; 136(2):364-77. PMC: 3273494. DOI: 10.1016/j.cell.2009.01.001. View

16.

Carey B, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M . Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A. 2008; 106(1):157-62. PMC: 2629226. DOI: 10.1073/pnas.0811426106. View

17.

Eiges R, Urbach A, Malcov M, Frumkin T, Schwartz T, Amit A . Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell. 2008; 1(5):568-77. DOI: 10.1016/j.stem.2007.09.001. View

18.

Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero M . Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature. 2009; 460(7251):53-9. PMC: 2720823. DOI: 10.1038/nature08129. View

19.

Kim J, Sebastiano V, Wu G, Arauzo-Bravo M, Sasse P, Gentile L . Oct4-induced pluripotency in adult neural stem cells. Cell. 2009; 136(3):411-9. DOI: 10.1016/j.cell.2009.01.023. View

20.

Shi Y, Desponts C, Do J, Hahm H, Scholer H, Ding S . Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell. 2008; 3(5):568-74. DOI: 10.1016/j.stem.2008.10.004. View